Bis(4-(bromomethyl)-N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide);4-(bromomethyl)-3-(trifluoromethyl)benzoic acid;6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)pyridin-3-amine;N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-4-propyl-3-(trifluoromethyl)benzamide
C102H95Br3F12N24O9 — CID 159960290
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(4-(bromomethyl)-N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide);4-(bromomethyl)-3-(trifluoromethyl)benzoic acid;6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)pyridin-3-amine;N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-4-propyl-3-(trifluoromethyl)benzamide
Bis(4-(bromomethyl)-N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide);4-(bromomethyl)-3-(trifluoromethyl)benzoic acid;6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)pyridin-3-amine;N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-4-propyl-3-(trifluoromethyl)benzamide (PubChem CID 159960290) has the molecular formula C102H95Br3F12N24O9 and a molecular weight of 2268.73 g/mol. Its IUPAC name is bis(4-(bromomethyl)-N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide);4-(bromomethyl)-3-(trifluoromethyl)benzoic acid;6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)pyridin-3-amine;N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-4-propyl-3-(trifluoromethyl)benzamide.
Molecular Properties
| Compound Name | Bis(4-(bromomethyl)-N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide);4-(bromomethyl)-3-(trifluoromethyl)benzoic acid;6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)pyridin-3-amine;N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-4-propyl-3-(trifluoromethyl)benzamide |
|---|---|
| PubChem CID | 159960290 |
| Molecular Formula | C102H95Br3F12N24O9 |
| Molecular Weight | 2268.73 g/mol |
| Exact Mass | 2264.51 |
| IUPAC Name | bis(4-(bromomethyl)-N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-3-(trifluoromethyl)benzamide);4-(bromomethyl)-3-(trifluoromethyl)benzoic acid;6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)pyridin-3-amine;N-[6-methyl-5-(8-morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-3-pyridinyl]-4-propyl-3-(trifluoromethyl)benzamide |
| SMILES | CCCc1ccc(C(=O)Nc2cnc(C)c(-c3cc(N4CCOCC4)c4nccn4n3)c2)cc1C(F)(F)F.Cc1ncc(N)cc1-c1cc(N2CCOCC2)c2nccn2n1.Cc1ncc(NC(=O)c2ccc(CBr)c(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)c2nccn2n1.Cc1ncc(NC(=O)c2ccc(CBr)c(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)c2nccn2n1.O=C(O)c1ccc(CBr)c(C(F)(F)F)c1 |
| InChI | InChI=1S/C27H27F3N6O2.2C25H22BrF3N6O2.C16H18N6O.C9H6BrF3O2/c1-3-4-18-5-6-19(13-22(18)27(28,29)30)26(37)33-20-14-21(17(2)32-16-20)23-15-24(35-9-11-38-12-10-35)25-31-7-8-36(25)34-23;2*1-15-19(21-12-22(34-6-8-37-9-7-34)23-30-4-5-35(23)33-21)11-18(14-31-15)32-24(36)16-2-3-17(13-26)20(10-16)25(27,28)29;1-11-13(8-12(17)10-19-11)14-9-15(21-4-6-23-7-5-21)16-18-2-3-22(16)20-14;10-4-6-2-1-5(8(14)15)3-7(6)9(11,12)13/h5-8,13-16H,3-4,9-12H2,1-2H3,(H,33,37);2*2-5,10-12,14H,6-9,13H2,1H3,(H,32,36);2-3,8-10H,4-7,17H2,1H3;1-3H,4H2,(H,14,15) |
| InChIKey | ODFVXEWPZLNVLK-UHFFFAOYSA-N |
| XLogP | 20.18 |
| TPSA | 372.82 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 150 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2268.73 |
| LogP ≤ 5 | 20.18 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 29 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159960290 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.